|

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

RECRUITINGN/ASponsored by Baker Heart and Diabetes Institute
Actively Recruiting
PhaseN/A
SponsorBaker Heart and Diabetes Institute
Started2024-07-01
Est. completion2025-10
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure. This program aims to improve cognition, reduce dementia risk and cardiovascular events, and will be supported by innovative digital technology for wide scale rollout and implementation. Findings from this research will transform the way healthcare is delivered to cognitively impaired patients with heart disease who have a very high risk of developing dementia.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Hospitalised with HF as primary or secondary diagnosis.
2. At least mild cognitive impairment (CI) based on Montreal Cognitive Assessment (MoCA) on hospital discharge.

Exclusion Criteria:

1. Unable to provide written consent; requiring palliative care; or participating in another RCT
2. Recovery of cognitive function shortly after hospital discharge: to ensure that we only include patients with "true" CI, any patients with a repeated MoCA\>25 at 2 weeks post-discharge will be excluded.
3. Terminal illness (eg. cancer) that may influence 12-month prognosis.

Conditions7

Cognitive ChangeCognitive DeclineCognitive ImpairmentDementiaHeart DiseaseHeart FailureLeft Ventricular Dysfunction

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.